Unlocking Precision
Revolutionizing early ovarian cancer detection with next-gen liquid biopsies driven by genomics and machine learning
Higher Performance than Other Approaches
By focusing on cell-free DNA and using proprietary Machine Learning algorithms to analyze unique methylation patterns, we are able to increase accuracy for ovarian cancer and bypass confounding conditions present in approaches that use non-ovarian cancer specific CA125.